2008-2017年澳大利亚和新西兰急性卒中后的长期生存、卒中复发与预期寿命损失:一项全人群队列研究
急性卒中后10年生存概率36.4%,卒中复发累积发生率26.8%,预期寿命平均损失5.5年(占预测寿命32.7%),出血性卒中死亡和复发风险高于缺血性卒中。
要点
- 急性卒中后10年生存概率36.4%,5年52.8%,1年73.0%,3个月79.4%。
- 卒中复发累积发生率10年26.8%,5年19.8%,1年11.0%,3个月7.8%。
- 出血性卒中较缺血性卒中死亡风险HR 2.02(95%CI 1.99-2.04),复发风险HR 1.63(95%CI 1.59-1.67)。
核心结论
- 在全人群研究中,急性卒中后死亡和卒中复发常见,急性卒中与相当大的预期寿命损失相关。
- 需要进一步改善卒中的治疗和二级预防以降低这些风险。
研究设计与样本
- 全人群队列研究,纳入2008年至2017年澳大利亚和新西兰所有公立医院及大多数私立医院首次卒中住院的成人。
- 缺血性卒中175,547例(56.1%),出血性卒中77,940例(24.9%),未特指卒中59,675例(19.1%)。
- 通过链接各区域死亡登记和后续住院记录随访至卒中后10年,采用灵活参数生存模型估计全因死亡、卒中复发和预期寿命损失,复发风险估计采用竞争风险模型。
主要发现
- 总体生存概率3个月为79.4%,1年为73.0%,5年为52.8%,10年为36.4%。
- 卒中复发累积发生率3个月为7.8%,1年为11.0%,5年为19.8%,10年为26.8%。
- 与缺血性卒中相比,出血性卒中与更高的死亡风险相关(HR 2.02,95%CI 1.99-2.04),也与更高的复发风险相关(HR 1.63,95%CI 1.59-1.67)。
- 女性(HR 1.10,95%CI 1.09-1.11)和年龄增长(≥85岁 vs 18-54岁:HR 7.36,95%CI 7.15-7.57)与死亡风险增加相关。
- 动脉粥样硬化性冠状动脉和非冠状动脉血管疾病、心律失常和糖尿病等多个危险因素与死亡和卒中复发风险增加相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Data on long-term outcomes following an acute stroke are sparse. We assessed survival, risk of recurrent stroke and loss in life expectancy following an acute stroke using population-wide data from Australia and New Zealand. METHODS: We included all adults with the first stroke hospitalization during 2008 and 2017 at all public and most private hospitals. Patients were followed up to 10 years after the stroke by linkage to each region's Registry of Deaths and subsequent hospitalizations. Flexible parametric survival modeling was used to estimate all-cause mortality, stroke recurrence, and loss in life expectancy. Competing risk model was used when estimating the risk of stroke recurrence. RESULTS: Three hundred thirteen thousand one hundred sixty-two patients were included (mean age 73.0±14.6 y, 52.0% males) with ischemic stroke (175 547, 56.1%) being the most common, followed by hemorrhagic stroke (77 940, 24.9%) and unspecified stroke (59 675, 19.1%). The overall survival probability was 79.4% at 3 months, 73.0% at 1 year, 52.8% at 5 years, and 36.4% at 10 years. Cumulative incidence of stroke recurrence was 7.8% at 3 months, 11.0% at 1 year, 19.8% at 5 years, and 26.8% at 10 years. Hemorrhagic stroke was associated with greater mortality (hazard ratio, 2.02 [95% CI, 1.99-2.04]) and recurrent stroke (hazard ratio, 1.63 [95% CI, 1.59-1.67]) compared with ischemic stroke. Female sex (hazard ratio, 1.10 [95% CI, 1.09-1.11]) and increasing age (≥85 years versus 18-54 years: hazard ratio, 7.36 [95% CI, 7.15-7.57]) were also associated with increased mortality. Several risk factors including atherosclerotic coronary and noncoronary vascular disease, cardiac arrhythmia, and diabetes were associated with increased risk of mortality and recurrent stroke. Compared with the general population, an acute stroke was associated with a loss of 5.5 years of life expectancy, or 32.7% of the predicted life expectancy, and was pronounced in patients with a hemorrhagic stroke (7.4 years and 38.5% of predicted life expectancy lost). CONCLUSIONS: In this population-wide study, death and recurrence of stroke were common after an acute stroke and an acute stroke was associated with considerable loss in life expectancy. Further improvements in treatment and secondary prevention of stroke are needed to reduce these risks.
引用
- Peng Y, Ngo L, Hay K, et al. Long-Term Survival, Stroke Recurrence, and Life Expectancy After an Acute Stroke in Australia and New Zealand From 2008-2017: A Population-Wide Cohort Study. Stroke. 2022. PMID: 35418238. doi:10.1161/STROKEAHA.121.038155
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。